/* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .footer { background: #f5f5f6; color: #555a62; font-size: 14px; line-height: 1.5; padding: 18px 0; } .footer-wrap { padding-left: 18px; padding-right: 18px; max-width: 1236px; margin: 0 auto; } .footer a { color: #0291db; } .footer a:hover { color: #0276b3; } .footer-row { display: flex; flex-wrap: wrap; justify-content: space-between; align-items: center; margin: -3px; } .footer-col { padding: 0 3px; } .footer-col-copyRight { justify-content: flex-start; } .footer-col-logo { justify-content: flex-end; } .footer-col-copyRight, .footer-col-logo { flex: 1; display: flex; } .logo { width: 120px; height: 28px; opacity: 0.6; } @media screen and (max-width: 768px) { .footer-row { display: block; } .footer-col { width: 100%; text-align: center; margin: 6px 0; } .footer-col:first-child { margin-top: 0; } .footer-col:last-child { margin-bottom: 0; } .footer-col-copyRight, .footer-col-logo { justify-content: center; } .logo { margin: 0 auto; } } /*# sourceMappingURL=styles.css.map */ /* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .region.region-footer { background-color: #1E1E23; padding: 20px; text-align: center; } .region.region-footer .block { max-width: 1264px; margin: 10px auto; color: #dddddd; } .region.region-footer .block a { color: #dddddd; font-size: 17px; } .region.region-footer .block a:hover, .csnfooter.small:hover { color: #ffffff; } #footer-links span.sep { color: rgb(151, 174, 206); font-size: 8px; display: inline-block; margin: 0 10px; line-height: 18px; vertical-align: text-top; } .csnfooter.small { font-size: 13px; margin-bottom: 15px; text-align: center; } @media only screen and (min-width: 768px) { .csnfooter.small { width: calc(100% - 348px); } } /*# sourceMappingURL=styles.css.map */ <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W7KNSFJ" height="0" width="0" style="display:none;visibility:hidden"></iframe>

Please remember that these discussion boards are a public forum, which means open to the public (i.e. non-CSN members) and the content can be found via internet search engines. Members are strongly advised not to share personal identifiers such as real names, email address, telephone number, street address, etc. This information can be used to identify you and link you to the content you provide. Other areas of CSN are restricted to members only and cannot be found by search engines.

Lung Cancer

Archives for August 2021

New here & about to meet with a Pulmonary Specialist to discuss my CT Scan results
I was recently in the ER for a BP issue and during the diagnosis I had a chest xray that showed some issues with my left lung. They did a CT scan and have found several masses in my lower left lung, the largest is 5.7cm, spiculated lung mass with several lympth nodes enlarged in the surrounding area. The lower portion of…
Clinical Trial KRAS G12C - Adagrasib (MRTX849) + TNO155 = Acne
Hello everyone, I have searched some terms and found no on point results, hence my new topic creation here. I have metastisised colon cancer with KRAS G12C mutation and have just started a drug trial with the new targeting drug, Adagrasib (Merati's MRTX849) combined with SHP2 inhibitor TNO155. I have 2 main side effects…

/* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .footer { background: #f5f5f6; color: #555a62; font-size: 14px; line-height: 1.5; padding: 18px 0; } .footer-wrap { padding-left: 18px; padding-right: 18px; max-width: 1236px; margin: 0 auto; } .footer a { color: #0291db; } .footer a:hover { color: #0276b3; } .footer-row { display: flex; flex-wrap: wrap; justify-content: space-between; align-items: center; margin: -3px; } .footer-col { padding: 0 3px; } .footer-col-copyRight { justify-content: flex-start; } .footer-col-logo { justify-content: flex-end; } .footer-col-copyRight, .footer-col-logo { flex: 1; display: flex; } .logo { width: 120px; height: 28px; opacity: 0.6; } @media screen and (max-width: 768px) { .footer-row { display: block; } .footer-col { width: 100%; text-align: center; margin: 6px 0; } .footer-col:first-child { margin-top: 0; } .footer-col:last-child { margin-bottom: 0; } .footer-col-copyRight, .footer-col-logo { justify-content: center; } .logo { margin: 0 auto; } } /*# sourceMappingURL=styles.css.map */ /* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .region.region-footer { background-color: #1E1E23; padding: 20px; text-align: center; } .region.region-footer .block { max-width: 1264px; margin: 10px auto; color: #dddddd; } .region.region-footer .block a { color: #dddddd; font-size: 17px; } .region.region-footer .block a:hover, .csnfooter.small:hover { color: #ffffff; } #footer-links span.sep { color: rgb(151, 174, 206); font-size: 8px; display: inline-block; margin: 0 10px; line-height: 18px; vertical-align: text-top; } .csnfooter.small { font-size: 13px; margin-bottom: 15px; text-align: center; } @media only screen and (min-width: 768px) { .csnfooter.small { width: calc(100% - 348px); } } /*# sourceMappingURL=styles.css.map */

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2023 © Cancer Survivors Network